BIOMAT Database Logo BIOMAT Database Logo

[Cellular and humoral immunity in chronic liver diseases]. 1980

A S Loginov, and T M Tsaregorodtseva, and M M Zotina, and A M Ponomarenko, and T K Shmeleva

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

A S Loginov, and T M Tsaregorodtseva, and M M Zotina, and A M Ponomarenko, and T K Shmeleva
[Humoral immunity in chronic liver diseases].
April 1974, Orvosi hetilap,
A S Loginov, and T M Tsaregorodtseva, and M M Zotina, and A M Ponomarenko, and T K Shmeleva
[Cellular immunity and chronic liver diseases].
January 1965, Folia allergologica,
A S Loginov, and T M Tsaregorodtseva, and M M Zotina, and A M Ponomarenko, and T K Shmeleva
[Changes in humoral and cellular immunity in chronic lymphoproliferative diseases].
January 1980, Medicinski pregled,
A S Loginov, and T M Tsaregorodtseva, and M M Zotina, and A M Ponomarenko, and T K Shmeleva
[Indices of cellular and humoral immunity in chronic myeloproliferative diseases].
January 1986, Terapevticheskii arkhiv,
A S Loginov, and T M Tsaregorodtseva, and M M Zotina, and A M Ponomarenko, and T K Shmeleva
Humoral and cellular immunity in chronic urticaria.
January 1979, Allergologia et immunopathologia,
A S Loginov, and T M Tsaregorodtseva, and M M Zotina, and A M Ponomarenko, and T K Shmeleva
[Cellular immunity in patients with chronic liver diseases].
January 1981, Terapevticheskii arkhiv,
A S Loginov, and T M Tsaregorodtseva, and M M Zotina, and A M Ponomarenko, and T K Shmeleva
[Humoral and cellular immune reactions in acute and chronic liver diseases].
March 1975, Orvosi hetilap,
A S Loginov, and T M Tsaregorodtseva, and M M Zotina, and A M Ponomarenko, and T K Shmeleva
Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity.
July 2001, Current molecular medicine,
A S Loginov, and T M Tsaregorodtseva, and M M Zotina, and A M Ponomarenko, and T K Shmeleva
[Humoral immunity and cellular hypersensitivity in liver cirrhosis].
May 1975, Sovetskaia meditsina,
A S Loginov, and T M Tsaregorodtseva, and M M Zotina, and A M Ponomarenko, and T K Shmeleva
[Humoral and cellular immunity in chronic lymphatic leukemia].
January 1980, Medicinski pregled,
Copied contents to your clipboard!